UNSPSC 85631939: Replacement of bilateral breast with nonautologous tissue substitute, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to replacement of bilateral breast with nonautologous tissue substitute, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0HRV0KZ

UNSPSC 85631939 Replacement of bilateral breast with nonautologous tissue substitute, open approach is a Commodity code that shows no relevant recent state and local procurement activity. The six recent opportunities associated with this code in the source material — independent medical evaluation services for pension benefit determinations (Phoenix), surgical carve-out benefits for municipal employees (Long Beach), occupational medical surveillance for ferry workers (Washington State Department of Transportation), emergency and specialty medical services for detained youth (Harris County), pharmacy benefit management (Collier County), and temporary health professional staffing (Santa Clara County) — are all administrative healthcare services, benefits management, and workforce staffing functions that bear no connection to surgical breast reconstruction procedures. The code's nominal scope describes a specific surgical intervention, yet the recent opportunities reflect procurement of medical administrative services, occupational health screening, youth detention healthcare, pharmacy operations, and clinical staffing placement.

State and local procurement offices rarely issue solicitations for specific surgical procedures under UNSPSC codes. This code appears to have been applied to these opportunities either in error during taxonomy assignment or as a catch-all placeholder for healthcare-related procurements that do not fit the code's actual definition. A business development professional evaluating whether to pursue work under this code should treat the recent-opportunities record as a false signal and seek clarification from issuing bodies on the intended scope before investing in proposal development.